Brief Summary
Type:
Leukemias
Study Type:
Treatment
Phase:
III
ClinicalTrials.gov Identifier:
NCT05183035
Study #:
CMH - APAL2020D
Start Date:
Sep 15, 2022
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT05183035
View Complete Trial Details & Eligibility at ClinicalTrials.gov
